Showing results (1951-1960 of 2,221) with videos related to
Sort By:
Pageof 223
Plos One|July 16, 2021
Self-management for chronic widespread pain including fibromyalgia: A systematic review and meta-analysisAdam W A Geraghty, Emma Maund, David Newell, et al.Toxins|December 22, 2022
Distinct Metabolic States Are Observed in Hypoglycemia Induced in Mice by Ricin Toxin or by FastingJacob Kempa, Galen O'Shea-Stone, Corinne E Moss, et al.Addiction (Abingdon, England)|December 2, 2022
COVID-19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systemsNoa Krawczyk, Bianca D Rivera, Cale Basaraba, et al.Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Metastatic Small Cell Carcinoma of the Lung: An Unusual Cause of Acute Fulminant Hepatic FailureRemegio Maglantay, Jia Qin, Sonali Lanjewar, et al.Cancer Immunology, Immunotherapy : CII|April 23, 2005
A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activationWu Peng, Xin Zhang, Nehal Mohamed, et al.The Journal of Clinical Investigation|September 1, 1994
Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone releaseM L Hartman, S M Pincus, M L Johnson, et al.Journal of Protein Chemistry|June 6, 2000
Identification of the site of inhibition of oncogenic ras-p21-induced signal transduction by a peptide from a ras effector domainL Chie, J M Chen, F K Friedman, et al.The Journal of Clinical Endocrinology and Metabolism|November 1, 1995
Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assayJ D Veldhuis, A Y Liem, S South, et al.The American Journal of Managed Care|February 1, 2017
Value-based payment in implementing evidence-based care: the Mental Health Integration Program in Washington stateYuhua Bao, Thomas G McGuire, Ya-Fen Chan, et al.Arthritis and Rheumatism|October 23, 1997
Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study GroupC M Stein, T Pincus, D Yocum, et al.Pageof 223